Instituto Bioclon S.A. de C.V. clinical trials
A subsidiary of Laboratorios Silanes S.A. de C.V.
The registry lists 11 studies whose lead sponsor is Instituto Bioclon S.A. de C.V.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 13, 2018.
Registry sponsor names on this page
- Instituto Bioclon S.A. de C.V.11 studies
Something wrong with this grouping? Tell us on the Laboratorios Silanes S.A. de C.V. page.
Studies
Recruiting first, then most recently updated. Showing 11 of 11. All Laboratorios Silanes S.A. de C.V. studies →
- A Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in MoroccoCompletedNCT01336660Phase 2/3
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- Black Widow Spider Antivenin for Patients With Systemic LatrodectismCompletedNCT00657540Phase 3
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite EnvenomationTerminatedNCT00639951Phase 4
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,CompletedNCT00868309Phase 2
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting EnvenomationCompletedNCT01599936Phase 3
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- The Efficacy and Safety of Aracmyn in Patients With Systemic LatrodectismCompletedNCT00247078Phase 2
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting EnvenomationCompletedNCT01599923Phase 3
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.CompletedNCT00636116Phase 3
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- Double-Blind, Alacramyn® vs. Placebo in Pediatric PatientsCompletedNCT00685230Phase 2/3
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting EnvenomationCompletedNCT00624078Phase 2/3
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.
- Establishment of Natural History of Scorpion EnvenomationCompletedNCT00696683
Sponsor listed in the registry: Instituto Bioclon S.A. de C.V.